Postural Control in Chronic Obstructive Pulmonary Disease

Korábbi kezelés

• Patients treated with oral or systemic corticosteroids (> 0.5 mg / kg / day for > 7 days)
• Patients treated with oral or systemic corticosteroids (> 0.5 mg / kg / day for > 7 days)

Más betegség

• Psychiatric pathologies or antecedent of behavioral disorders
• Any condition that, in the opinion of the investigator, could increase and compromise the safety of the person in the event that he / she participates in the study
• Psychiatric pathologies or antecedent of behavioral disorders
• Any condition that, in the opinion of the investigator, could increase and compromise the safety of the person in the event that he / she participates in the study

Egyéb

• COPD patients :
• Alcoholism, i.e. > 21 glasses a week for men and >14 glasses a week for women
• Contraindication to the application of a magnetic field (i.e. right hip arthroplasty, pelvic / abdominal surgeries)
• Severe vision or hearing problems not corrected
• Patient oxygen dependent
• Patients in exclusion period from another research protocol
• Pregnant women (known pregnancy) or lactating women
• Patient deprived of liberty by a judicial or administrative decision
• Patient subject to a legal protection measure or unable to express their consent
• Patient who is not sufficiently fluent in reading and understanding the French language to be able to consent to participate in the study
• Patient unable to follow study procedures and to respect visits throughout the study period
• Person with a medical history that, in the opinion of the investigator, could interfere with the results of the study
• Any other reason that, in the opinion of the investigator, could interfere with the evaluation of the aims of the study
  • Healthy volunteers:
• Alcoholism, i.e. > 21 glasses a week for men and >14 glasses a week for women
• Contraindication to the application of a magnetic field (i.e. right hip arthroplasty, pelvic / abdominal surgeries)
• Severe vision or hearing problems not corrected
• Subjects in exclusion period from another research protocol
• Pregnant women (known pregnancy) or lactating women
• Regular physical activity with a frequency greater than 3 sessions per week
• Participant deprived of liberty by a judicial or administrative decision
• Participant subject to a legal protection measure or unable to express their consent
• Participant who is not sufficiently fluent in reading and understanding the French language to be able to consent to participate in the study
• Participant unable to follow study procedures and to respect visits throughout the study period
• Person with a medical history that, in the opinion of the investigator, could interfere with the results of the study
• Any other reason that, in the opinion of the investigator, could interfere with the evaluation of the aims of the study

• COPD patients :
• GOLD II - III or IV
• FEV1 <80% of predicted values
• Men and women aged 40 years and over
• French-speaking participant
• BMI <30 kg / m²
• Stable condition (i.e. without exacerbation) for more than 15 days
• Able to express their consent in writing prior to any participation in the study
• Affiliates or beneficiaries of a social security
• Minimum score of 26 on the MMSE questionnaire of 3 months or less
  • Healthy volunteers :
• Men and women aged 40 years and over
• French-speaking participant
• BMI <30 kg / m²
• No known chronic respiratory, cardiovascular, metabolic, renal or neuromuscular pathologies
• Able to express their consent in writing prior to any participation in the study
• Affiliates or beneficiaries of a social security
• Minimum score of 26 on the MMSE questionnaire of 3 months or less
  • For all participants :
  • -Subject who has not objected to the reuse of data collected